Newsroom | 70138 results

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Obsidian Therapeutics, Inc., a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lymphocyte (TIL) cell therapies, today announced positive Phase 2 results in patients with advanced melanoma from the Phase 1/2 Agni-01 multicenter study of OBX-115. These data will be presented in an oral presentation by Allison S. Betof, M.D., Ph.D., FASCO, associate professor of medicine (oncology),...

MILWAUKEE--(BUSINESS WIRE)--Mayville Engineering Company (NYSE: MEC) (the “Company” or “MEC”), a leading value-added provider of design, prototyping and manufacturing solutions serving diverse end markets, today announced the closing of its underwritten public offering of 5,000,000 shares of its common stock at a public offering price of $20.00 per share, for total gross proceeds of $100 million, before deducting underwriting discounts and commissions and other offering expenses payable by MEC....

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that management will participate in the following upcoming conferences: Stifel 2026 Virtual Ophthalmology Forum Date: Tuesday, May 26, 2026 Format: Meetings and Webcast Fireside Chat Details: Investor meeting participation is by invitation only from the sponsoring brokerage firm. Webcas...

BERKELEY, Calif.--(BUSINESS WIRE)--OpenFE tooling provides accurate, high throughput binding affinity predictions at a quality that will have real-world impact on drug discovery...

LAS VEGAS & CHARLOTTE, N.C.--(BUSINESS WIRE)--Certerra, a leading provider of technology-enabled testing, inspection, and certification (“TIC”) services for critical infrastructure, today announced a strategic partnership with Southern Engineering, a provider of geotechnical engineering, construction materials testing, and special inspections to public and private sector clients in the Mid-Atlantic. This transaction strengthens Certerra’s presence in the Southeast, enhancing the Company’s capab...

COPENHAGEN, Denmark--(BUSINESS WIRE)--Skape Bio and researchers at the University of Washington’s Institute for Protein Design (IPD) today announced a peer-reviewed study published in the leading international journal Nature demonstrating a new way to design protein-based medicines for G protein-coupled receptors, or GPCRs, one of the most important classes of drug targets in medicine. GPCRs are cell-surface receptors that help the body respond to signals such as hormones, neurotransmitters, an...

ARLINGTON, Va.--(BUSINESS WIRE)--Rune Technologies, which builds AI-enabled predictive software for military logistics in contested environments, today announced its integration into Project Dynamis, the U.S. Marine Corps' command and control modernization initiative. Rune’s TyrOS platform is designed to build on the Marine Corps service-level investments in the Maven Smart System, with specific focus on active tactical workflow configuration underway for logistics and sustainment across the Ma...

EDISON, N.J.--(BUSINESS WIRE)--MTF Biologics, a global nonprofit leader in tissue-based solutions, today announced the appointment of New Horizon Medical Solutions (NHMS) as the exclusive distributor of AmnioBand® Membrane to wound care specialists, podiatrists, and mobile care practitioners across the United States. The agreement combines AmnioBand's peer-reviewed Level 1 clinical evidence base with NHMS's specialized provider network and hands-on field support, creating a distribution model p...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the successful completion of its previously announced acquisition of Tubulis GmbH, a private Germany-based, clinical-stage biotechnology company developing next-generation antibody-drug conjugates (ADCs). The acquisition brings Gilead next-generation ADC assets and a platform designed to maximize patient benefit through more selective delivery of diverse payloads to tumors. Tubulis’ technologies enable th...

LONDON--(BUSINESS WIRE)--AV Laboratories, a science-led skincare company founded by pioneers in IVF solutions, regenerative medicine, and stem cell therapy, today announced it will exhibit at the 42nd Annual Meeting of the European Society of Human Reproduction and Embryology, ESHRE 2026, taking place in London from 5 - 8 July 2026. The company will welcome clinicians, embryologists, fertility specialists, researchers, partners, and industry participants at Booth A22. “ESHRE is deeply personal...